Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

At this time, I suspect your doctor will order some radiology tests, possibly a bone scan to look for the distant spread of ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Then on April 28, it elevated to 29.3 ng/mL, at which time my oncologist prescribed an ... DEAR DR. ROACH: I have three ...

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

I am sorry, but it is very likely that the cancer has come back somewhere in your body. However, this is not 100 per cent ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...